Skip to main content

Table 1 Total patients analysed and integration sites identified

From: HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP

 

Kagoshima

 

Kumamoto

 
 

HAM/TSP

 

AC

 

AC

 

Number of patients in:

Strong HBZ

Weak HBZ

Total

Strong HBZ

Weak HBZ

Total

Strong HBZ

Weak HBZ

Total

Whole cohort

81

148

229

92

110

202

34

64

98

All LM-PCR

42

62

104

41

59

100

34

64

98

LM-PCR QC pass

39

56

95

30

38

68

24

51

75

Number of UIS* with abundance:

<1 per 10,000 PBMC

7954

12341

20295

1451

5485

6936

4572

9744

14316

1-10 per 10,000 PBMC

10051

12429

22480

2178

2515

4693

1034

1853

2887

>10 per 10,000 PBMC

219

364

583

102

67

169

42

40

82

All

  

43358

  

11798

  

17285

  1. *UIS identified from LM-PCR QC pass samples only.
  2. AC: Asymptomatic carrier, UIS: Unique integration site, QC pass: samples that passed LM-PCR quality controls (QC).